Sima Lev reccomends: Regulation of the epithelial control gene p63 by oncogenes and the Hippo signaling pathway
MOROSS – Integrated Cancer Center (MICC) cellpress https://weizmann.zoom.us/j/5065402023?pwd=a3Z6KzRCU0xJaUFoM2Y5emZwZm1oZz09
Drug Resistance
Sima lev recommend: PYK2, a hub of signaling networks in breast cancer progression
Trends In Cell Biology cellpress https://authors.elsevier.com/a/1hb3t3QxxSr7Kn
Sima lev recommend: Early-Stage Triple-Negative Breast Cancer: Optimizing Therapy
Breast Cancer: Optimizing Therapy THE ASCO POST Continue
Sima lev recommend: Updates in Triple-Negative Breast Cancer Treatment
Oncology Nursing News, February 2023 Oncology nurses provide perspective on the changing standards of care for patients with triple-negative breast cancer. Continue
Sima Lev’s lab – Combination Therapy & Drug Resistance
Combination Therapy & Drug Resistance TNBC – Triple-Negative Breast Cancer – accounts for approximately 20 percent of all breast cancer patients and can be divided […]
Cell Death & Disease: PYK2 negatively regulates the Hippo pathway in TNBC by stabilizing TAZ protein
Read the article of Prof. Sima Lev and others, which was published on “The journal Cell Death & Disease” in 2018: PYK2 negatively regulates the […]